Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) Enterprise Value (2018 - 2026)

Arvinas (ARVN) posted quarterly Enterprise Value of -$614.9 million for Q1 2026, up 35.57% year-over-year from -$453.6 million in Q1 2025, and up 10.29% quarter-over-quarter from -$685.4 million in Q4 2025.

Analysis

Arvinas (ARVN) Enterprise Value (2018 - 2026) Analysis & Trends

Arvinas' Enterprise Value history runs 10 years deep, the most recent figure standing at -$614.9 million for Q1 2026.

  • In Q1 2026, Enterprise Value rose 35.57% year-over-year to -$614.9 million; the TTM figure through Mar 2026 stood at -$614.9 million (up 35.57% YoY), while the FY2025 annual figure was -$685.4 million, up 34.06% from the prior year.
  • Enterprise Value for Q1 2026 stood at -$614.9 million, up from -$685.4 million in the prior quarter.
  • The five-year high for Enterprise Value was -$66.8 million in Q1 2022, with the low at -$1.2 billion in Q1 2024.
  • The 5-year median for Enterprise Value is -$160.3 million (2024), against an average of -$436.2 million.
  • The sharpest annual moves came in 2022 and 2025: Enterprise Value surged 91.06% in 2022, then sank 824.41% in 2025.
  • Arvinas' Enterprise Value stood at -$86.8 million in 2022, then sank by 265.44% to -$317.2 million in 2023, then slumped by 227.68% to -$1.0 billion in 2024, then surged by 34.06% to -$685.4 million in 2025, then grew by 10.29% to -$614.9 million in 2026.
  • Business Quant data shows ARVN's Enterprise Value at -$614.9 million in Q1 2026, -$685.4 million in Q4 2025, and -$787.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Arvinas 609.77 Mn 41.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.26 Mn
Mar 31, 2026 68.80 Mn
Dec 31, 2025 67.71 Mn
Sep 30, 2025 -184.38 Mn
Jun 30, 2025 -322.45 Mn
Mar 31, 2025 -441.84 Mn
Dec 31, 2024 279.50 Mn
Sep 30, 2024 570.48 Mn
Jun 30, 2024 597.43 Mn
Mar 31, 2024 1.65 Bn
Dec 31, 2023 1.02 Bn
Sep 30, 2023 961.00 Mn
Jun 30, 2023 1.23 Bn
Mar 31, 2023 1.32 Bn
Dec 31, 2022 1.73 Bn
Sep 30, 2022 2.23 Bn
Jun 30, 2022 2.14 Bn
Mar 31, 2022 3.51 Bn
Dec 31, 2021 4.24 Bn
Sep 30, 2021 2.79 Bn